Letters, Testimony & Comments

BIO submits letters, testimony, and comments to government and regulatory bodies throughout the United States and around the world.

Featured Letters, Testimony, & Comments
BIO Letter to HRSA on 340B Rebate Model
Under the 340B program, participating manufacturers must offer 340B pricing on their covered outpatient drugs by covered entities, as a condition of having those drugs federally payable under Medicare Part B and Medicaid. Critically, Congress…
CSBA Letter to Congressional Leadership on…
BIO Comments to the USPTO’s MAY 10, 2024 Proposed…
BIO submitted these comments in response to the United States Patent and Trademark Office’s May 10, 2024, Notice of Proposed Rulemaking regarding Terminal Disclaimer Practice to Obviate Nonstatutory Double Patenting.
All Letters, Testimony & Comments
  • Show All
Search
Results
March 10, 2016
BIO urges support from the U.S. Department of Agriculture for FDA’s release of the final risk assessment on animal cloning.
March 10, 2016
NIST includes biomanufacturing as an area of "critical national need" for 2010 TIP competition.
March 10, 2016
Centers for Disease Control & Prevention, Clinician Outreach and Community Activity (COCA) Conference Call July 27, 2010.
March 10, 2016
May 2010 National Security Strategy from the White House
March 10, 2016
NIST clarifies that device development is not a focus of 2010 TIP competition.
March 10, 2016
The National Vaccine Program was established in 1986 to achieve optimal prevention of infectious diseases through immunization and optimal prevention of adverse reactions to vaccines.
March 10, 2016
The environmental challenges of weed resistance are the same for biotech crops and conventional crops if farmers do not use herbicides as directed. Learn more about stewardship practices that help farmers better control weeds and how biotechnology…
March 10, 2016
This Report contains NVAC recommendations based on the Working Group’s findings and conclusions, and includes recommendations developed by the NVAC Adolescent Working Group. It takes into account public comments and extensive stakeholder input…
March 10, 2016
White House National Security Council - November 2009 National Strategy for Countering Biological Threats
March 10, 2016
The 2009 Government-Business Forum on Small Business Capital Formation recommended a permanent exemption for small companies from Section 404(b) of Sarbanes-Oxley. Additionally, they recommended that the SEC increase the public float threshold for…